Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/2/2026

Hospitalized Adults with Uncontrolled Diabetes, Severe Shoulder Pain, and Multidrug‑Resistant Urinary Tract Infection

1. Immediate Glycemic Management

  • Discontinue all oral hypoglycemic agents on admission because continuation is associated with undesirable glucose excursions and a three‑fold higher risk of severe hyperglycemia in hospitalized patients. 1
  • Calculate the total daily insulin dose based on body weight:
  • Administer insulin as 50 % basal (glargine or detemir) and 50 % rapid‑acting nutritional insulin given before each meal. 1
  • Avoid sliding‑scale insulin as sole therapy; it provides no proven benefit and increases hypoglycemia risk and glucose variability. 1
  • Use correction (supplemental) insulin doses only after basal‑bolus dosing, selecting the appropriate sensitivity column (insulin‑sensitive, usual, or insulin‑resistant) based on patient characteristics. 1
  • Monitor bedside glucose at least four times daily (pre‑meal and bedtime) to maintain target 140–180 mg/dL. 1
  • Obtain an HbA1c measurement during the hospital stay to guide discharge glycemic plan. 2

2. Management of Multidrug‑Resistant Urinary Tract Infection

  • Obtain urine and blood cultures immediately in any adult with severe infection; blood cultures are mandatory for systemic illness. [3][4]
  • Start empirical parenteral broad‑spectrum antibiotics promptly; for multidrug‑resistant organisms consider carbapenems (e.g., imipenem 0.5 g TID or meropenem 1 g TID) or newer agents such as ceftolozane/tazobactam, ceftazidime/avibactam, or meropenem‑vaborbactam, guided by local resistance patterns. 3
  • Recognize diabetes as a complicating factor, classifying the infection as a complicated UTI that requires 7–14 days of therapy. [3][5]
  • Diabetic adults have approximately a two‑fold higher risk of UTI and are more likely to be infected with resistant pathogens. 3
  • Optimizing glucose control reduces infection severity and improves outcomes in diabetic patients with UTI. 6
  • Monitor renal function closely; when eGFR < 60 mL/min/1.73 m², assess for chronic kidney disease complications. 6
  • Treat for 7–14 days; extend to 14 days in males when prostatitis cannot be excluded. 3
  • Reassess clinical response and culture results within 48–72 hours and adjust antibiotics accordingly. [3][9]

3. Evaluation of Severe Shoulder Pain in the Context of Uncontrolled Diabetes

  • Urgently assess for septic arthritis or osteomyelitis in any diabetic adult with severe shoulder pain and concurrent infection, given the risk of hematogenous spread. [4][7]
  • Consider diabetic adhesive capsulitis as a common musculoskeletal complication in this population. 8
  • Screen for diabetic neuropathy (temperature, pinprick, vibration, pressure, ankle reflexes) when shoulder pain is present. 8
  • Obtain plain radiographs first to identify bony involvement. 4
  • If osteomyelitis or deep soft‑tissue infection is suspected, perform MRI, which provides detailed anatomy of sinus tracts, abscesses, and muscle involvement. [4][7]
  • When septic arthritis is suspected, conduct urgent arthrocentesis and obtain tissue specimens rather than superficial swabs for accurate culture. 4
  • Use ultrasonography or CT to detect deep soft‑tissue abscesses when indicated. 4

4. Common Pitfalls to Avoid

  • Do not continue metformin in patients with impaired renal function or systemic illness due to risk of lactic acidosis. 1
  • Do not treat asymptomatic bacteriuria in diabetic adults; there is no benefit and it promotes resistance. 5
  • Do not delay surgical consultation when severe infection, extensive gangrene, necrotizing infection, or deep abscess is suspected. 7
  • Do not assume shoulder pain is purely musculoskeletal without ruling out infection in uncontrolled diabetics with concurrent MDR infection. [4][7]

5. Ongoing Monitoring and Follow‑up

  • Check serum creatinine and potassium regularly, especially if the patient receives ACE inhibitors or ARBs. 6
  • Evaluate for diabetic kidney disease (present in ~20–40 % of diabetics) by measuring urinary albumin‑to‑creatinine ratio and eGFR. 6

All statements are supported by the cited references indicated in brackets.